Baxter International, Inc. BAX recently announced that it has entered into a definitive agreement to divest its Vantive ...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February 13, 2025 at 7:30 a.m. Central Time ...
The Clear Oral Syringes Segment Held the Largest Share in 2024, Accounting for 62.9% of Total Revenues Oral Syringes Market ...
Baxter’s BioPharma Solutions business is pleased to announce that the company’s oncology manufacturing facility expansion in Halle, Germany is ...